PUK11 COST-MINIMIZATION ANALYSIS- MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74521-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)74521-6/fulltext
Title :
PUK11 COST-MINIMIZATION ANALYSIS- MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74521-6&doi=10.1016/S1098-3015(10)74521-6
First page :
Section Title :
Open access? :
No
Section Order :
450